Tonghua Golden-Horse Stock Hits Day Low Amid Price Pressure, Closing at CNY 21.56

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. experienced a significant decline today, with the stock dropping by 9.98% and reaching an intraday low of CNY 21.56. This performance starkly contrasts with the China Shanghai Composite, which gained 1.16% on the same day. Over the past week, the stock has decreased by 9.53%, while its one-month performance shows a decline of 6.95%. In terms of annual performance, Tonghua Golden-Horse has faced a challenging year, with a decrease of 14.95%, significantly underperforming the China Shanghai Composite's 18.97% gain. Year-to-date, the stock is down 21.57%. Financial metrics indicate that the company has struggled with profitability, reflected in a low Return on Capital Employed (ROCE) of 2.62% and a Return on Equity (ROE) of 1.37%. Additionally, the company has reported negative results for the last three consecutive quarters, with net profit declining by 58.14%. Despite being net-debt free, the company has shown poor long-term growth, with net sales decreasing at an annual rate of 2.78% over the past five years.